Nucor Corporation vs BIO-TECHNE Corp — how do they compare? Nucor Corporation trades at $230.8 (market cap $52.55B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Nucor Corporation is far larger — about 4.7× BIO-TECHNE Corp's market cap, and Nucor Corporation pays the higher dividend (0.97%). Which is the better fit depends on your goals.
| NUE | TECH | |
|---|---|---|
Market Cap | $52.55B | $11.16B |
Sector | Basic Materials | Health |
52-Week High | $266.35 | $72.12 |
52-Week Low | $131.78 | $43.31 |
Enterprise Value | $57.19B | $11.24B |
Dividend Yield | 0.97% | 0.45% |
Trailing returns across standard periods
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →